Join
Live feed
·
PRReleasevia Quantisnow
Elutia Inc. logo

Elutia Reports Third Quarter 2025 Financial Results; Closes $88 Million Sale of BioEnvelope Business to Boston Scientific Corporation; Funds NXT-41x Development

ByQuantisnow·Wall Street's wire, on your screen.
ELUT· Elutia Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ELUT (Elutia Inc.) and more on Quantisnow.